Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II StudyJoshua Bauml, Robert I. Haddad, Stephen V. Liu et al.|Journal of Clinical Oncology|2017Cited by 653
Safety and Efficacy of Pembrolizumab With Chemoradiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase IB StudySteven Powell, William C. Spanos, Kathryn A. Gold et al.|Journal of Clinical Oncology|2020Cited by 119